Anchor price 30.46 on closest trading day on/after 2025-03-13. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-22 | Slingsby Brian Taylor | director | Sale | 104,320 | $28.81 | $3.01M |
| 2026-08-10 | Ferguson James J. III | officer | Award | 102,400 | — | — |
| 2026-08-10 | Ferguson James J. III | officer | Award | 135,000 | $27.38 | $3.70M |
| 2026-08-10 | Rodman David Malcom | officer | Option exercise | 2,170 | $16.00 | $35K |
| 2026-08-10 | Rodman David Malcom | officer | Sale | 2,170 | $27.09 | $59K |
| 2026-07-15 | Rodman David Malcom | officer | Sale | 6,349 | $26.61 | $169K |
| 2026-07-13 | Congleton Jon | director, officer | Sale | 10,700 | $27.24 | $291K |
| 2026-07-13 | Rodman David Malcom | officer | Option exercise | 3,542 | $10.20 | $36K |
| 2026-07-13 | Rodman David Malcom | officer | Option exercise | 4,167 | $14.25 | $59K |
| 2026-07-13 | Rodman David Malcom | officer | Option exercise | 6,349 | $1.08 | $7K |
| 2026-07-13 | Rodman David Malcom | officer | Sale | 14,058 | $27.58 | $388K |
| 2026-07-09 | Rodman David Malcom | officer | Option exercise | 2,171 | $16.00 | $35K |
| 2026-07-09 | Rodman David Malcom | officer | Sale | 2,171 | $30.30 | $66K |
| 2026-06-17 | Rodman David Malcom | officer | Option exercise | 4,167 | $14.25 | $59K |
| 2026-06-17 | Rodman David Malcom | officer | Option exercise | 417 | $15.44 | $6K |
| 2026-06-17 | Rodman David Malcom | officer | Sale | 4,584 | $25.00 | $115K |
| 2026-06-17 | Karydas Daphne | director | Option exercise | 3,000 | $12.02 | $36K |
| 2026-06-17 | Karydas Daphne | director | Sale | 3,000 | $25.00 | $75K |
| 2026-06-15 | Rodman David Malcom | officer | Option exercise | 3,542 | $10.20 | $36K |
| 2026-06-15 | Rodman David Malcom | officer | Sale | 9,890 | $23.81 | $235K |
| 2026-04-15 | Rodman David Malcom | officer | Sale | 6,348 | $27.66 | $176K |
| 2026-04-13 | Congleton Jon | director, officer | Sale | 15,730 | $26.83 | $422K |
| 2026-04-13 | Rodman David Malcom | officer | Option exercise | 6,349 | $1.08 | $7K |
| 2026-04-13 | Rodman David Malcom | officer | Option exercise | 3,542 | $10.20 | $36K |
| 2026-04-13 | Rodman David Malcom | officer | Option exercise | 4,167 | $14.25 | $59K |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2025-03-17 | SCHEDULE | Samsara BioCapital, L.P. | 9.10% | 5,736,305 | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-26 | SCHEDULE 13G | Alector, Inc. | — | — | view → |
| 2026-10-22 | SCHEDULE 13G | Frazier Life Sciences Acquisition Corp. II | — | — | view → |
| 2026-09-22 | SCHEDULE 13G | BetterLife Pharma Inc. | — | — | view → |
| 2026-09-21 | SCHEDULE 13D/A | SIONNA THERAPEUTICS, INC. | 14.30% | 6,476,193 | view → |
| 2026-09-17 | SCHEDULE 13D/A | TYRA BIOSCIENCES, INC. | — | 14,130,492 | view → |
| 2026-09-03 | SCHEDULE 13G | JATT III Acquisition Corp | — | — | view → |
| 2026-08-17 | SCHEDULE 13G | Latigo Biotherapeutics, Inc. | — | — | view → |
| 2026-08-14 | SCHEDULE 13D/A | SEPTERNA, INC. | — | 5,525,324 | view → |
| 2026-08-11 | SCHEDULE 13D/A | Wave Life Sciences, Inc. | — | 34,314,406 | view → |
| 2026-08-10 | SCHEDULE 13D/A | SAB Biotherapeutics, Inc. | — | 9,609,852 | view → |
| 2026-07-23 | SCHEDULE 13D/A | ARTIVA BIOTHERAPEUTICS, INC. | — | 18,415,956 | view → |
| 2026-07-22 | SCHEDULE 13D/A | Freenome, Inc. | — | 15,367,270 | view → |
| 2026-07-21 | SCHEDULE 13D/A | VOR BIOPHARMA INC. | — | 12,937,855 | view → |
| 2026-07-20 | SCHEDULE 13G | Agenus Inc. | — | — | view → |
| 2026-07-07 | SCHEDULE 13D/A | Climb Bio, Inc. CLYM | 33.00% | 23,249,186 | view → |
| 2026-07-02 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | 4.10% | 1,985,541 | view → |
| 2026-06-26 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | 6.00% | 2,915,742 | view → |
| 2026-06-24 | SCHEDULE 13D/A | SOLID BIOSCIENCES INC. SLDB | — | 12,036,126 | view → |
| 2026-06-22 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | — | 3,654,307 | view → |
| 2026-06-18 | SCHEDULE 13D | Parabilis Medicines, Inc. PBLS | 23.80% | 28,933,371 | view → |
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →